share trade concern regard increment opex due reinvest
think misguid management explicitli note januari guidanc call although
guidanc assum reinvest tax benefit intend tax reform
pass view reinvest posit think better posit
realiz full potenti aet sooner
concern regard increment opex reinvest misguid view
share trade due concern regard increment oper expens
least least full run-rat result reinvest
tax benefit better wage benefit compani workforc
invest data analyt care management solut invest store pilot
enhanc servic offer howev think concern misguid management
note guidanc call januari guidanc provid time
includ reinvest benefit tax reform given tax legisl
pass yet fact management remark explicitli investor consid take
advantag financi flexibl tax reform make strateg invest
growth busi includ de-lever rapidli previous plan
exactli updat new guidanc assum updat guidanc
result reinvest signifi deterior core busi
believ deploy tax benefit better posit long term
view deploy tax benefit better posit compani
long term specif post acquisit aet think initi could
help realiz benefit aet acquisit sooner expect think
make sens provid higher wager employe prepar expand
role care deliveri post-aet also think earlier roll-out pilot could yield
substanti benefit realiz full potenti cvs-aet combin sooner
rather later could acceler realiz revenu synergi lastli
deploy least half tax benefit toward debt repay result management
achiev target leverag ratio target within two year longer-
pro-forma model indic share under-valued current level
adj ep estim per pro-forma model indic share
under-valued current level appli rel modest price-to-earnings multipl
adj ep estim discount back two year discount rate get
share price note signific second full year post-
aet management expect realiz meaning benefit transact notabl
believ upsid pro-forma estim given assum modest growth
legaci pbm retail/ltc busi outer year assum revenu
synergi aet transact
pleas see page report import disclosur
posit near term strong pbm busi well long
term posit health reform integr pbm/ retail busi model
believ manag steer compani right direct number
long-term growth driver cah/cv sourc jv grow clinic busi
pharmaci advisor coram still see favor risk/reward think
core hold healthcar investor
 clarifi aet
 top-lin growth retail/ltc
revenu pbm revenu
 oper margin modestli
y/i due increment oper expens
reinvest mix shift toward
pbm segment
 assum share repo
 strong retail comp better macro
environ coupl better pbm
 stronger gener lower
 sooner expect close aet
debt paydown greater
 slower expect growth
 weaker expect gener
greater expect reimburs
 less expect debt paydown
one largest drug retail chain compani larg oper
two main busi segment pharmaci servic retail pharmaci
retail pharmaci segment compani oper drugstor on-line retail
pharmaci websit well health clinic store sell prescript drug
wide array gener merchandis refer front end product
compani also provid full rang pbm servic client mainli includ
organ sponsor health benefit plan servic includ formulari
servic diseas manag program pharmacogenom servic
cowen compani
lower adj ep estim
respect howev maintain price target base revis
dcf analysi impli share trade adj ep estim
current multipl
use five-year discount cash flow analysi primari valuat method
deriv price target gener assum discount rate may appli
appropri adjust depend compani and/or industri specif factor also
assum termin growth rate depend long-term view specif
sub-industri coverag note discount rate assumpt could view
conserv rel actual weight averag cost capit view
assumpt reason long run lower discount rate assumpt
increas termin growth rate assumpt would lead higher estim valu
per share secondari measur look forward price-to-earnings multipl ev/sal ratio
impli dcf analysi compar histor averag
see number risk associ drug retail space industri highli
competit retail drugstor chain independ pharmaci mail-ord provid
well retail includ groceri store mass merchant warehous club on-line
store compet space could pressur front-end sale margin
current wave drug patent expir posit impact profit
deriv gener expect taper significantli next sever year
specialti provid signific tailwind part believ
could concern around sustain high growth area
believ impact ppaca expect increas volum could subdu
depend implement execut
regulatori approv acquisit aet lower expect
guidanc later expect roll-on contract
author research report herebi certifi view express research report accur reflect person view subject
secur issuer ii part compens relat directli indirectli specif recommend view express report
cowen compani llc affili make market stock secur
cowen compani llc compens research analyst activ servic intend benefit firm investor client individu compens determin research
analyst includ author report base varieti factor includ overal profit firm total revenu deriv sourc includ
revenu invest bank sale trade princip trade revenu cowen compani llc compens research analyst base specif invest
bank transact specif sale trade princip trade revenu
research report simultan avail client client websit research report client research report dissemin e-mail
made avail third-parti aggreg cowen compani llc respons redistribut research third parti aggreg select research report
avail print form addit electron form publish research report obtain firm client websit http //cowenlibrari bluematrix com/client/
inform opinion estim forecast date report subject chang without prior notif seek updat research appropri
variou regul may prevent us research report publish irregular interv appropri analyst judgement
inform subject secur may obtain offic research report publish sole inform purpos constru offer
sell solicit offer buy secur state offer solicit would illeg disclosur relat cowen compani llc
inform herein base sourc believ reliabl guarante us purport complet statement summari avail data
opinion express herein statement judgment date subject chang without notic opinion recommend herein take
account individu client circumst object need intend recommend invest strategi recipi report must make
independ decis regard secur subject research report case secur financi instrument may difficult valu sell reliabl
inform valu risk relat secur financi instrument may difficult obtain extent report discuss legal proceed issu
prepar express intend express legal conclus opinion advic salespeopl trader profession may provid oral written
market commentari trade strategi client reflect opinion contrari opinion express research princip trade area invest
busi may make invest decis inconsist recommend view express research cowen compani llc maintain physic electron
procedur inform barrier address flow inform among depart within cowen compani llc order prevent avoid conflict
interest respect analyst recommend
import disclosur regard compani subject research report pleas contact complianc depart cowen compani llc lexington
avenu floor new york ny addit import disclosur except valuat method risk avail firm disclosur
websit http //cowen bluematrix com/sellside/disclosur action
equiti research price target cowen compani llc assign price target compani cover equiti research unless note otherwis equiti research price target
issuer stock repres valu analyst reason expect stock reach perform period twelv month price target equiti secur
report consid context prior publish cowen compani llc equiti research report includ disclosur equiti report
firm disclosur websit may may includ equiti research price target well develop relat issuer industri financi market
equiti research price target valuat methodolog risk associ achiev given equiti research price target pleas see analyst equiti research report
publish target
cowen credit research trade due natur fix incom market issuer debt secur issuer discuss cowen credit research trade
research report assign rate price target may continu follow accordingli investor must regard brand report provid stand-alon
analysi reflect analyst opinion date report expect continu analysi addit report relat issuer debt secur
time time cowen credit research trade research analyst provid invest recommend secur subject report
recommend intend time date public within paramet specifi individu report cowen credit research trade
invest recommend made strictli case-by-cas basi recommend provid part overarch rate system set consist
appli benchmark view express report may differ view offer firm equiti research report prepar client
notic uk investor public produc cowen compani llc regul unit state finra commun person kind
describ articl servic market act promot order must transmit person without
notic european union investor individu produc recommend requir obtain certain licens financi regulatori author finra review
author current licens statu histori employ histori report regulatori custom disput crimin matter via brokercheck finra http //
brokercheck finra org/ individu licens statu finra constru endors finra gener biograph inform also avail
research analyst www cowen com
addit complet preced recommend histori relat recommend research report avail http //cowen bluematrix com/sellside/
recommend contain report produc februari et dissemin februari et
copyright user agreement gener inform relat report
cowen compani llc right reserv member nyse finra sipc research report prepar exclus use cowen client may
reproduc display modifi distribut transmit disclos whole part form manner other outsid organ without express prior
written consent cowen cowen research report distribut simultan client elig receiv research report unauthor use disclosur
